Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 5

Nearly All Drugs Pass China’s Second National Drug Quality Report For 2013

The Second Drug Quality Announcement of 2013 was released by China FDA, reporting that 99.3% of the 2,885 batches of 18 drugs passed evaluations.

Aveo says partner Astellas will not seek EU nod for kidney cancer drug

(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe.

U.S. lawmaker would give FDA more oversight of drug compounding

WASHINGTON, May 23 (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug com...

Merck halts development of experimental Parkinson's drug

May 23 (Reuters) - Merck & Co has ended development of preladenant, an experimental drug for Parkinson's disease, after initial data from three late-stage trials proved disappointing.

Alzheimer's drug was too good to be true, studies find

It sounded too good to be true and unfortunately it was.  Three research studies out Thursday severely diminish the hope that a cancer drug already on the market could be an Alzheimer’s treatment. In February 2012 scientists at Case Western University Medical Center re …

Bad pharma: how drug companies mislead doctors and harm patients Ben Goldacre 2012 Faber & Faber £13.99, $28.00

NHS accused of incompetence over Tamiflu stockpiling

The NHS has been accused of "shocking incompetence" after it wrote off £74m worth of influenza vaccine doses when they became unusable after being stored incorrectly. The chairman of the House of Commons Public Accounts Committee Marga...

BNF updates include TB dose changes

The doses of rifampicin and ethambutol in the treatment regimen for tuberculosis have been increased in this month’s British National Formulary and BNFC updates to reflect recommendations from the World Health Organization and the European Medicin...

UPDATE 4-New J&J anti-depressant related to 'Special K' party drug

NEW BRUNSWICK, N.J., May 23 (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications.

Taro Provides Results Year Ended March 31, 2013

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three months and year ended March 31, 2013. Quarter ended March 31, 2013 Highlights - compared to March 31, 2012 Net sales of $165.1 million, increased $20.0 million, or 13.8%, however, volumes h...

The FDA Responds To Steve Nissen’s Criticism Of Upcoming Avandia Meeting

This morning, I published a guest post from Steven Nissen, Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic, alleging that the most likely rationale for an upcoming panel meeting being held by the Food and Drug Administra...

Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center

The firm is actively filing Tylenol lawsuits on behalf of those who allegedly suffered liver damage and other serious complications related to their use of Tylenol. (PRWEB) May 23, 2013 The Rottenstein Law Group LLP, a New York-based nationwide mass torts law firm, has created the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol, dedicated to issues that apply to Tylenol users...

Alkermes’ Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013, at 8:40 a.m. EDT (1:40 p.m. BST) from The Westin Boston Waterfront Hotel. The presentation may be accessed under the Investors tab on www.alkermes.com and will b...

Marijuana tied to better blood sugar control

NEW YORK (Reuters Health) - People who had used marijuana in the past month had smaller waists and lower levels of insulin resistance - a diabetes precursor - than those who never tried the drug, in a new study.

Doubt Cast on Potential Alzheimer's Treatment

Four research teams have been unable to replicate a finding of a 2012 study that showed how an existing cancer drug reversed signs of Alzheimer's disease in the brains of mice.

U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation

Parker Waichman LLP is proud to announce that Matthew J. McCauley, Senior Litigation Counsel at the law firm, has been appointed Co-Lead Counsel in the Mirena IUD multidistrict litigation. The MDL centralizes lawsuits that allege injuries from the Mirena IUD, such as uterine perforation, to the Southern District of New York. New York, New York (PRWEB) May 23, 2013 Parker Waichman LLP, a national...

Drug Eases Constipation from Opioids (CME/CE)

ORLANDO (MedPage Today) -- A peripherally acting opioid receptor antagonist alleviated opioid-induced constipation in two pivotal phase III trials, a researcher reported here.

[Cardeas Pharma] closes $34mm Series B round

Three-year-old [Cardeas Pharma Corp.] (developing therapies for multi-drug-resistant bacterial infections) brought in $34mm in its Series B round led by first-time backer HIG BioVentures, which adds a board member. Other new investor Delphi Ventures...

J&J Eyes Brazil, China, India, Other Emerging Markets For 10-Drug Rollout

Johnson & Johnson is targeting Brazil, China, India and other emerging markets for a planned global rollout of 10 new drugs by 2017, in addition to improving more than 25 existing ones.

Studies Cast Doubt on Cancer Drug as Alzheimer's Treatment

From Nature magazine [More]

Molina Healthcare of California Selected to Participate in the Covered California Marketplace

Molina Healthcare, Inc. (NYSE: MOH) today announced that its wholly owned subsidiary, Molina Healthcare of California, has been selected by Covered California to offer certified Qualified Health Plans (QHPs) on the California Health Benefit Exchange for the individual Health Maintenance Organization (HMO) market. Molina Healthcare will participate in four...

Labs reject dramatic findings on cancer drug in Alzheimer's mice

CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true.

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

First Manhattan adds Denner, others to Vivus slate

Vivus Inc. (NASDAQ:VVUS) investor First Manhattan Co. added three additional nominees, including Alex Denner, to its slate of proposed directors for the biotech's board. Denner had been a managing director of entities associated with Carl Icahn since...

J&J downplays biosimilar competition

Uptake in Korea of Remsima infliximab, a biosimilar version of autoimmune drug Remicade infliximab, has been "relatively slow," according to Kim Taylor, company group chairman, pharmaceuticals, Asia Pacific at Johnson & Johnson (NYSE:JNJ). J&J market...